Altre lingue Theracryf Plc

Azioni

EVG

GB00BSVYN304

Tempo differito London S.E. Altri mercati azionari 10:00:15 13/05/2024			Variaz. 5gg	Var. 1 gen.
0,8 ^GBX	+6,67%		+6,67%	-50,00%

26/04	Evgen Pharma plc cambierà il suo ticker in TCF da EVG	CI
04/04	Evgen Pharma conclude l'offerta di azioni al dettaglio	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Evgen Pharma plc will Change its Ticker to TCF from EVG	26/04
Evgen Pharma plc will Change its Name to TheraCryf plc	26/04
Norcros sells Johnson Tiles UK; Trifast trading well	25/04
Northcoders launches bootcamp; Schroder invests	04/04
Evgen Pharma Concludes Retail Offer of Shares	04/04
Evgen Pharma plc - Retail Offer	20/03
Evgen Pharma plc - Acquisition, Fundraising and Change of Name	20/03
Evgen Pharma Signs Takeover Deal with Chronos Therapeutics; Raises Capital Via Share Issue, Subscription	20/03
EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat	19/03
Evgen Pharma plc agreed to acquire Chronos Therapeutics Ltd. from group of shareholders for £3.4 million.	19/03
Evgen Pharma finds evidence of SFX-01 activity in colon cancer models	27/02
Evgen Pharma plc Announces That the Laboratories of Professor Grace Chen, Associate Professor Justin Colacino, and Professor Duxin Sun At the University of Michigan, Usa Have Observed Activity of Sfx-01 in Models of Colon Cancer	27/02
Evgen Pharma plc - Positive update on SFX-01 in vitro Glioblastoma studies	20/02
Evgen Pharma shares up on studies into SFX-01 product progressing well	19/02
Evgen Pharma plc Announces That the Laboratory of Dr Marjolein Geurts, Neuro-Oncologist At the Erasmus University Medical Centre Has Observed Continuing Activity of Sfx-01 in Gbm Cells	19/02
Apax opts against lifting offer; DCI enters loan deal	09/02
FTSE 100 falls at end of tepid week	09/02
Evgen Pharma Issues Notice of Dispute to Stalicla Over Missed Milestone Payment	09/02
Evgen partner raises USD17.4 million to support pipeline	16/01
Evgen Pharma plc announced that it has received $17.4 million in funding from Stalicla SA	16/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Theracryf Plc

Azioni

EVG

GB00BSVYN304

Altre lingue

Filtri